• Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only from 6:00 PM Eastern time on Tuesday, December 24 until 10:00 PM Eastern time on Wednesday, December 25. During this time, all posts will be available for view. However, no one will be able to make new posts during this time.


PIPs already?!













Definitely flaws here at the company, but I have to say too many entitled experienced reps are on this. The ones with 10-20 years of GI experience but can’t win 2 years in a row.

Make excuses all you want, but there are some reps in KY, TX, GA, FL, SC, MI, & CA, who are blowing it out besides NY. Yeah NY is and yes it’s BS how easy they have a Medicaid preferred coverage Blink pharmacy in NY, but the other reps in other states have found a way to win.
Thank your Shawn
 


















Bottom line is that if there is an opening....and there are a lot of them.....then somebody got fired, was about to get fired and quit, or just quit because the company ph'ing sucks. Sure there may have been some bad reps in there like anywhere else but not all of them, and anyone who joins this cluster'ph of a company will find themselves in the same spot in less than a year.

The territories that are doing well have exceptional coverage....here's looking at you NY with your low cost (free) medicaid coverage....pretty easy to get rx with that.

I would like to award this post extra points for its proper use of ph...well done, kudos to you.
 






I thought I'd make it till the end of the year without a PIP, but I just got mine out of the blue on a field ride last Thursday. I spent the weekend updating my resume.
I'm so sorry for you. I got my PIP last week also.i think they are trying to get rid of as many of us as possible right now to cut costs. I bet this place declairs bankruptcy in 2025.
 


















In case anyone needs a good look…
PHATHOM
PHARMACEUTICALS

Performance Issue

Based on analysis of launch performance for the 1st half of 2024, your territory was determined to be underperforming. In addition, we have evaluated territory performance in Q3. Your territory has been flagged as underperforming for this launch period as well. As a result, your territory is being placed on a performance improvement plan. We will reevaluate the territory performance 30 days from today.
Performance Standards
The territory performance must meet the following criteria to be considered progressing and no longer underperforming:
  • The territory must meet or exceed the TRx growth% of the nation.
  • The territory must meet or exceed the NRX growth% of the nation
  • The territory must meet or exceed the national average for new writer acquisition. Weekly Expectations
  • Progress with target accounts to be discussed on weekly calls and tracked via Veeva
  • Day to day planning focused on following sales direction, implementing clinical pieces to uncover clinical rationale and treatment practices.
  • 1:1 calls, we will review current sales performance based on the weekly report. Please be ready to discuss how your weekly sales compare to your weekly sales goal
  • We will also discuss your scheduled activity for the upcoming week (in-services, lunches, provider meetings, etc.).
  • Scheduled activity for the upcoming week should be emailed to RSM no later than COB every Friday.
  • CC me on all follow-up communications to customers. The email communications should reinforce the next steps in the sales process between you and the customer and the expectations agreed upon from each of you. We are committed to helping you elevate your performance and to consistently meet expectations to ensure a successful future at Phathom. I look forward to supporting you in meeting these goals. We must see consistent, incremental, and ongoing progress in the areas mentioned above.
 






























In case anyone needs a good look…
PHATHOM
PHARMACEUTICALS

Performance Issue

Based on analysis of launch performance for the 1st half of 2024, your territory was determined to be underperforming. In addition, we have evaluated territory performance in Q3. Your territory has been flagged as underperforming for this launch period as well. As a result, your territory is being placed on a performance improvement plan. We will reevaluate the territory performance 30 days from today.
Performance Standards
The territory performance must meet the following criteria to be considered progressing and no longer underperforming:
  • The territory must meet or exceed the TRx growth% of the nation.
  • The territory must meet or exceed the NRX growth% of the nation
  • The territory must meet or exceed the national average for new writer acquisition. Weekly Expectations
  • Progress with target accounts to be discussed on weekly calls and tracked via Veeva
  • Day to day planning focused on following sales direction, implementing clinical pieces to uncover clinical rationale and treatment practices.
  • 1:1 calls, we will review current sales performance based on the weekly report. Please be ready to discuss how your weekly sales compare to your weekly sales goal
  • We will also discuss your scheduled activity for the upcoming week (in-services, lunches, provider meetings, etc.).
  • Scheduled activity for the upcoming week should be emailed to RSM no later than COB every Friday.
  • CC me on all follow-up communications to customers. The email communications should reinforce the next steps in the sales process between you and the customer and the expectations agreed upon from each of you. We are committed to helping you elevate your performance and to consistently meet expectations to ensure a successful future at Phathom. I look forward to supporting you in meeting these goals. We must see consistent, incremental, and ongoing progress in the areas mentioned above.
Even if you aren’t on a pip you’re stupid to launch new drug for a leadership team like this. I would drive my car into a ditch and go on medical leave. It’s not worth it, what a collective of pond scum.